Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

1.1K
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

654
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
654
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

572
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
572
Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

598
In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs...
598
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

331
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
331
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

643
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
643

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and Immunogenicity of Varicella Vaccination in Children and Adolescents Living With HIV: A Systematic Review.

The Pediatric infectious disease journal·2026
Same author

Varicella-Zoster Virus Testing in Clinical Practice in the U.S., 2016-2023.

American journal of preventive medicine·2025
Same author

Characteristics of reported mumps cases in the United States: 2018-2023.

Vaccine·2024
Same author

Real-Time Use of a Dynamic Model To Measure the Impact of Public Health Interventions on Measles Outbreak Size and Duration - Chicago, Illinois, 2024.

MMWR. Morbidity and mortality weekly report·2024
Same author

Development of COVID-19 vaccine policy - United States, 2020-2023.

Vaccine·2023
Same author

Vaccine value profile for cytomegalovirus.

Vaccine·2023
Same journal

A Communicating Anomalous Vessel Between the Brachial and Radial Artery: A Cadaver Case Report.

The American journal of case reports·2026
Same journal

Vacuum Scaling Drainage in the Treatment of Infected Elbow Charcot Neuroarthropathy: A Case Report and Literature Review.

The American journal of case reports·2026
Same journal

Diagnostic Challenge of Sequential Appendicitis in a Patient With Appendiceal Duplication: A Case Report.

The American journal of case reports·2026
Same journal

Surgical Septal Myectomy and Atrial Myxoma Resection: Two Diseases, One Heart, and a Case Report.

The American journal of case reports·2026
Same journal

Dermatitis Artefacta: A Multidisciplinary Approach.

The American journal of case reports·2026
Same journal

Pancreatic Adenocarcinoma Presented as Paraneoplastic Dermatomyositis Complicated with Rhabdomyolysis: Case Report and Review.

The American journal of case reports·2026
See all related articles

Related Experiment Video

Updated: Mar 31, 2026

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

10.7K

Chromobacterium Violaceum Sepsis: Rethinking Conventional Therapy to Improve Outcome.

Kathleen R Richard1, Joshua J Lovvorn1, Sara E Oliver1

  • 1Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL, USA.

The American Journal of Case Reports
|October 20, 2015
PubMed
Summary
This summary is machine-generated.

Chromobacterium violaceum infections, though rare, can cause severe sepsis and multi-organ failure. Early identification and appropriate, prolonged antimicrobial therapy are crucial for successful treatment and preventing relapse.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Chromobacterium violaceum is a Gram-negative bacterium found in tropical/subtropical soil and water.

More Related Videos

Quantification of Violacein in Chromobacterium violaceum and Its Inhibition by Bioactive Compounds
07:13

Quantification of Violacein in Chromobacterium violaceum and Its Inhibition by Bioactive Compounds

Published on: August 8, 2025

2.0K
A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats
05:56

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats

Published on: February 20, 2021

2.6K

Related Experiment Videos

Last Updated: Mar 31, 2026

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

10.7K
Quantification of Violacein in Chromobacterium violaceum and Its Inhibition by Bioactive Compounds
07:13

Quantification of Violacein in Chromobacterium violaceum and Its Inhibition by Bioactive Compounds

Published on: August 8, 2025

2.0K
A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats
05:56

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats

Published on: February 20, 2021

2.6K
  • Human infections are rare but associated with high morbidity, antimicrobial resistance, and potential for relapse.
  • Bacteremia, disseminated infection, and ineffective antimicrobials predict mortality.